Earth Science Tech, Inc. (OTC: ETST) reported financial results for the fiscal year ended March 31, 2026, highlighting revenue growth and higher earnings. The company posted revenue of $35.7 million, an 8% increase from the prior year, and gross profit of $25.5 million, up 5%. Net income rose 11% to $3.6 million compared with fiscal 2025. Total assets increased 27% year over year to $9.0 million as the company continued expanding its integrated healthcare platform across telemedicine, pharmacy, and fulfillment services.
The company also emphasized its capital allocation strategy, noting it repurchased and retired more than 4 million shares during fiscal 2026 and more than 7.1 million shares through fiscal 2026 and subsequent periods. Management stated that the company generated positive operating cash flow, strengthened its balance sheet without adding debt, and remains focused on growth initiatives, product expansion, and continued share repurchases as it enters fiscal 2027.
Earth Science Tech operates as a diversified holding company focused on the health and wellness sector. Its principal operating strategy is to build a vertically integrated healthcare platform that combines compounding pharmacy operations, telemedicine platforms, clinical support, and direct-to-patient fulfillment. The company’s healthcare operations are supported by investments in real estate and asset management activities and a consumer products business. The core of the company’s value proposition is the seamless integration of patient care, from consultation to fulfillment, achieved through the synergy of specialized subsidiaries.
For more details, the full press release is available at https://ibn.fm/NpjTw. The latest news and updates relating to ETST can be found in the company’s newsroom at https://ibn.fm/ETST.
